Obesity Trial, Recruiting NCT06119516 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06119516
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People with a BMI over 40 kg/m², which is classified as class III (severe) obesity
  • People diagnosed with moderate or severe ARDS (a serious lung condition that makes breathing very difficult), as defined by a specific medical standard called the Berlin definition
  • People where no more than 72 hours have passed since their ARDS was first diagnosed at the moderate or severe level
  • People who are on a breathing machine through a tube placed in the windpipe (invasive mechanical ventilation)
  • Cases where informed consent has been given by the patient or a close family member, with the possibility of enrolling in an emergency and obtaining consent afterward
  • People with or without a COVID-19 diagnosis

Who may not be able to join:

  • People for whom a nasogastric tube (a tube passed through the nose into the stomach) cannot safely be used — for example, due to uncontrolled blood clotting problems, very low platelet counts, nasal injury, or enlarged veins in the oesophagus
  • People who have a medical order in place to limit or withhold life-sustaining treatments
  • People currently being supported by an ECMO machine (a device that takes over the work of the heart and lungs)
  • People who have already been on invasive mechanical ventilation for more than 96 hours
  • People with raised pressure inside the skull
  • People with an active air leak around the lungs, such as a collapsed lung (pneumothorax) or air in the chest cavity around the heart (pneumomediastinum)
  • People who are pregnant or breastfeeding
  • People receiving state medical aid (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jean-Luc MD Diehl, PhD, AP-HP, Hôpital Européen Georges Pompidou, Paris

Phone: 01 44 84 17 38

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 April 2024
Est. completion
4 April 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

The absolute value of the difference between the PEEP levels determined by esophageal pressure-guided strategy and by the PEEP level indicated by the maximal recruitment arm of the ExPress trial

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov